Status:
COMPLETED
A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease
Lead Sponsor:
Pfizer
Conditions:
Gaucher Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a multi-center trial to further extend the assessment of the safety and efficacy of taliglucerase alfa in adult subjects (≥18 years old) with Gaucher disease who have enrolled in Protocol PB-0...
Eligibility Criteria
Inclusion
- Successfully completed Protocol PB-06-001 and enrolled in Protocol PB-06-003
- The subject signs an informed consent
Exclusion
- Currently taking another investigational drug for any condition.
- Presence of any medical, emotional, behavioral or psychological condition that in the judgment of the Investigator would interfere with the subject's compliance with the requirements of the study.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01422187
Start Date
August 1 2011
End Date
September 1 2014
Last Update
April 19 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.